Half-year report · HY
3939.TEDINET S100Y3HG
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥765m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.0bn | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥670m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥670m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥7.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥6.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥6.2bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.9bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.0bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.6bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥821m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥551m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥236m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥744m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥539m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥516m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥651m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥486m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.12 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.42 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.93 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 71.5% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥78m |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥44m |
| Healthy Lifespan Extension Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥714m |
| Healthy Lifespan Extension Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥714m |
| Healthy Lifespan Extension Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥111m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥2.1bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥2.1bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥3m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥950m |
| Solutions Development Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥412m |
| Solutions Development Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥338m |
| Solutions Development Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥74m |
| Solutions Development Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥16m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥74m |
| Healthy Lifespan Extension Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥551m |
| Healthy Lifespan Extension Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥551m |
| Healthy Lifespan Extension Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥57m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥737m |
| Solutions Development Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥344m |
| Solutions Development Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥330m |
| Solutions Development Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥14m |
| Solutions Development Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥839m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中野 秀俊 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)梶野 健 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 2661188000 | JPY |
| Net sales (5-year summary) | InterimDuration | 3134723000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5500786000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 764435000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 1009999000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1612858000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 518485000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 670149000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1111528000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 519104000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 717235000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1122962000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 4054275000 | JPY |
| Net assets (5-year summary) | InterimInstant | 5010609000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 4649304000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 6156984000 | JPY |
| Total assets (5-year summary) | InterimInstant | 7009291000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 6542237000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 10.93 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 14.12 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 23.42 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.658 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.715 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.711 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 551497000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 820843000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1292904000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -538822000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -235593000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -743548000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -486194000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -515616000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -651111000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 2947365000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 3419429000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3327111000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 48132000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 48132000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 48132000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 48132000 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 13680000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.2882 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |